Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 30, 2025American Journal of Clinical Oncology

Risk Model Based On Neutrophil-Related Genes Constructs to Assess Prognosis and Immune Landscape in Diffuse Large B-Cell Lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

GXGao XinfangXLXin-guo LuoHYHong-wei Ye

Discussion

Loading...

Member takes

Overview

Risk stratification model predicts survival outcomes in DLBCL patients, highlighting the role of the tumor microenvironment and cytokine pathways.

Key Points

  • The risk stratification model differentiates survival rates based on neutrophil-related genes in DLBCL.
  • The model's predictive efficacy was validated using receiver operating characteristic curves.
  • Analysis revealed distinct immune cell infiltration patterns and pathways related to different risk levels.
  • This approach emphasizes the importance of the tumor microenvironment and related gene functions in lymphoma studies.

Cite This Study

Xinfang et al. (2025) studied this question.

synapsesocial.com/papers/692b9da91d383f2b2a37a403https://doi.org/10.1097/coc.0000000000001272
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Integrated multi-omics analysis identifies prognostic risk genes and constructs a predictive signature in diffuse large B-cell lymphoma2026
  2. 2Exploration of biomarkers for predicting the prognosis of patients with diffuse large B-cell lymphoma by machine-learning analysis2025 · 1 citations
  3. 3Real-world patient-based next-generation sequencing assessments identify a high-risk subgroup and associated gene signature in diffuse large B cell lymphoma2025
  4. 4Establishment of a prognostic model for diffuse large B-cell lymphoma based on mitochondrial energy metabolism-related genes2025
  5. 5Identification of Bacterial Lipopolysaccharide-Related Molecular Subtypes and Development of a Four-Gene Prognostic Risk Model in Cervical Cancer.2025